Daven Mody

Daven Mody has over 20 years of experience in the pharmaceutical industry. Daven's current role is Vice President, Regulatory Affairs and Quality at Ocelot Bio, a position they have held since 2022. Prior to this, they were Senior Vice President, Global Regulatory Affairs, Quality, and Safety / Project Team Lead at Blade Therapeutics from 2019 to 2021. From 2016 to 2018, they were Senior Director, Regulatory Affairs at Theravance Biopharma US, Inc. From 2011 to 2015, they were Director, Regulatory Affairs at Impax Specialty Pharma. From 2008 to 2010, they were Associate Director, Regulatory Affairs at Medivation, Inc. From 2005 to 2007, they were Associate Director, Global Regulatory Affairs at ALZA Corporation/ Johnson & Johnson. From 2004 to 2005, they were Manager, Regulatory Affairs at CoTherix, Inc. From 2002 to 2003, they were Manager, Regulatory Affairs at Genentech. From 2001 to 2002, they were Associate Director, Medical Information at Matrix Pharmaceuticals, Inc. Daven's first role in the pharmaceutical industry was Manager, Medical Communications at ALZA Corporation from 2000 to 2001.

Daven Mody obtained a PharmD from the University of the Pacific in Pharmaceutical Science, an MBA from Cal State East Bay- College of Business & Economics in International Finance, Strategic Marketing Management, and Computer Information Systems, and a BS from the University of Illinois Chicago in Biochemistry.